Note
Ficus is a genus of the family Moraceae that comprises about 150 species distributed worldwide. 1) Most of the members of the family are very high trees, shrubs and rarely herbs often with milky juice. 1) A number of Ficus species are used as food and medicines in Traditional Chinese Medicine (TCM). Their uses, however, originated and are most widely found in the Middle East.
2) Ficus species are widely used in traditional medicine in Cameroon too. A mixture of powdered leaves of F. mucuso and palm oil are used in the treatment of epilepsy in Fongo Tongo, a village of the Western Region of Cameroon.
3) A decoction of stem bark is used in the East Region of Cameroon by Baka pygmies to treat jaundice. 4) Plants of the genus Ficus are known as sources of biologically active compounds such as 3-keto-urs-12-ene, a-amyrin, a-amyrin acetate, b-amiryn, b-amiryn acetate, boswellonate, b-sitosterol, b-sitosterone, stigmasterol, lupeol and lupenone. 5, 6) In the previous study on the figs of F. mucuso, we reported the isolation of isoderrone and alpinumisoflavone as its major constituents. 7) In continuation of our investigation for the search of bioactive constituents of F. mucuso, we examined the methanolic extract of the stem bark.
In this paper we report the isolation and the characterization of two new sphingolipids mucusamide (1) and mucusoside (2) .
Results and Discussion
Repeated column chromatography of the MeOH extract of the stem bark of F. mucuso, followed by purification on silica and sephadex column, afforded seventeen compounds, including cellobiosylsterol (3), 8, 9) b-sitosterol (4), 10) stigmasterol (5), 11) b-sitosterol 3-O-b-D-glucopyranoside (6), 12) lupeol acetate (7), 13) ursolic acid (8), 14) procatechuic acid (9), 15) 2-methyl-5,7-dihydroxychromone 8-C-b-D-glucoside (10), 16) apigenin (11), 17) (Ϫ)-epicatechin (12), 18) (ϩ)-catechin (13), 18) N-benzoyl-L-phenylalanilol (14), 19) a-acetylamino-phenylpropyl a-benzoylamino-phenylpropionate (15), 10) asperphenamate (16) 19) and benjaminamide (17) 20) (Fig. 1 ). Mucusamide (1) was isolated as a colourless powder mp 125-126°C. Its molecular formula was assigned as C 41 H 79 NO 6 with the aid of its High Resolution (HR)-FAB-MS which showed the pseudo-molecular ion peak [MϩH] ϩ at m/z 682.5931 (Calcd, 682.5986 for C 41 H 80 NO 6 ), containing three degrees of unsaturation. The IR spectrum showed absorption bands for hydroxyl and amide functions (3200-3500 cm
Ϫ1
) and an amide carbonyl group (1660 cm Ϫ1 22) Analysis of the 1 H-1 H correlation spectroscopy (COSY), heteronuclear multiple quantum coherence (HMQC) and heteronuclear multiple bond connectivity (HMBC) spectra ( (Fig. 3) . The above characteristic fragments ion peaks obtained after the cleavage of the disulfide bond, indicated that the two double bonds in 1 were located at C-7 and C-11 (Fig. 4) . The geometry of the two double bonds was determined to be trans as evidenced by the chemical shift of C-6 (34.0), C-9 (32.1), C-10 (32.1) and C-13 (33.3). Typically, the signals of a carbon next to a trans double bond appear at dϷ32, while those of a cis double bond appear at dϷ27.
24) The relative and absolute stereochemistry at the chiral centers C-2 to C-5 has already been established in similar molecules. 25) Based on the biogenetic considerations, the absolute stereochemistry of C-2, C-3, C-4 and C-5 in 1 was then proposed as 2S, 3S, 4R, 5R. This was confirmed by 13 C-NMR data of C-2 (53.0), C-3 (76.9), C-4 (73.0) and C-5 (72.9) which were in agreement with those of nubenamide reported in the literature. 25) Based on these evidences, mucusamide (1) could be assigned the structure (2S,3S,4R,5R,7E,11E)-2-{[(2R)-2-hydroxytetracosanoyl]amino}heptadeca-7,11-diene-1,3,4,5-tetrol.
Mucusoside (2) ). The 1 H-and 13 C-NMR spectra were typical for a sphingosine type skeleton like in 1 with a sugar unit, and possessing 2-hydroxy fatty acid and a b-glucopyranosyl moiety ( Table 1) .
Assignments of all protons and carbons in 2 could be made by When cerebroside 2 was treated with methanolic hydrochloric acid, a FAME was obtained together with LCB and methylglucopyranoside (Fig. 5) . Gas chromatographymass spectrometry (GC-MS) analysis of the FAME showed methyl 2(R)-2-hydroxytetracosanoate {EI: m/z 398, [a] D 20 Ϫ3.25°(in CHCl 3 )}, 23) and confirming the existence of a double bond in the LCB moiety. The EI-MS of the dimethyldisulfide (DMDS) derivative of 2 showed a characteristic fragment ion peak at m/z 131 [MeSCHC 5 H 11 ] ϩ due to the cleavage between the carbons bearing the methylthio groups. Therefore, the double bond in LCB moiety of 2 was located at C-12. Moreover, the cis geometry (Z) of the double bond was determined from d values 27.5 (C-11) and 27.9 (C-14) of the allylic carbons.
The absolute configuration of the glucopyranosyl moiety was determined as b-D-form by comparing the sign of the optical rotation and spectral data of methyl-b-D-glucopyranoside obtained from 2 with those of an authentic sample. 26, 27) The relative stereochemistry of 2 at C-2, C-3, C-4 was proposed as 2S, 3S, 4R, identical to that of D-sphingosine on the basis of 13 C-NMR spectral data, since the chemical shifts of C-2 (51.7), C-3 (75.9) and C-4 (72.5) were in agreement with those reported in the literature. b-D-glucopyranoside] (cellobiosylsterol), was previously isolated from the rice bran as a colourless amorphous powder. Previous determination of its structure was based on chemical transformations and mass spectrometry. We reported here for the first time its 1 H-and 13 C-NMR data, and signal assignments of 3 based on the COSY, HSQC and HMBC connectivities ( Table 2) .
Experimental
General Experimental Procedure Melting points were obtained on a Gallenkamp melting point apparatus. Optical rotations were measured with a JASCO DIP-360 polarimeter. UV spectra were recorded on a Hitachi UV 3200 spectrophotometer. A JASCO 320-A spectrophotometer was used for scanning IR spectroscopy using KBr pellets. 1D-and 2D-NMR spectra were run on Bruker spectrometer operating 75, 100, 125, 150, 300, 400, 500 and 600 MHz where chemical shifts (d) were expressed in ppm with reference to the solvent signals (in the case of mixture of CD 3 ODϩCDCl 3 , some drops of CDCl 3 were added to complete the dissolution of the sample and the reference was CD 3 OD signal). EI-MS spectra were obtained on Varian MAT 311A mass spectrometer. FAB-MS spectra were measured on a JOEL-HX 110 mass spectrometer. Column chromatography was performed on silica gel. Fractions were monitored by TLC using Merck pre-coated silica gel sheets (60 F 254 ), and spots were visualized by heating silica gel plates sprayed with ceric sulfate reagent solution.
Plant Material The stem bark of F. mucuso was collected in March, 2005 from Ngoa-Ekelle, Yaounde, Central Region of Cameroon and identified by Mr. Nana Victor, botanist at the National Herbarium, where the voucher specimen is deposited (HN no. 41204) .
Extraction and Isolation The air-dried and powdered stem bark (5.5 kg) of F. mucuso was extracted with MeOH (15 l) (1 week, repeated three times) at room temperature. The extract was then concentrated to dryness under vacuum at 40°C to give 290 g of dark brownish crude extract. The extract was subjected to medium pressure liquid column chromatography over silica gel eluting with n-hexane, n-hexane/EtOAc, EtOAc and EtOAc/MeOH, in increasing order of polarity. One hundred and fifty subfractions, each containing 500 ml, were collected and combined according to their TLC profiles on pre-coated silica gel 60 F 254 plates developed with n-hexane/EtOAc and CHCl 3 /MeOH mixture to give 6 fractions (F1-6). Fraction F1 was subjected to CC over silica gel, eluted with n-hexane/EtOAc mixture starting from 100% n-hexane to 50% of the mixture. This resulted in the isolation of lupeol acetate (7) (2.05 g), b-sitosterol (4) (115 mg), stigmasterol (5) (8 mg) and ursolic acid (8) (10 mg). Fraction 2 was also subjected to successive CC using the same quality of silica and eluted with a mixture of EtOAc and n-hexane (1 : 9-100% EtOAc) to give: asperphenamate (16) (14 mg) and a-acetylamino-phenylpropyl a-benzoylaminophenylpropionate (15) (3 mg), N-benzoyl-L-phenylalanilol (14) (5 mg).
Fraction 3 was eluted with the same mixture with different polarity (3 : 7 to 100% EtOAc) to give apigenin (11) Table 1 .
Mucusoside Table 1 . Table 2 .
Methanolysis of 1 and 2 Compounds 1 and 2 (1 mg each) were heated separately with 5% HCl in MeOH (1 ml) at 70°C for 12 h in a sealed smallvolume vial. The reaction mixture of each compound was extracted with n-hexane and the hexane layer was concentrated to give FAME for GC-MS analysis. The MeOH layer was concentrated in vacuo to give LCB-1 part for 1 and the mixture LCB-2 part and methyl glycoside for 2.
To determine the nature of LCB and the methyl glycoside, the process was repeated from 10 mg of 1 and 2. The MeOH layer from the methanolysis of 1 was suspended in H 2 O and LCB-1 (3.4 mg, 73.5%) was extracted with EtOAc. GC-MS Analysis of FAME from Compounds 1 and 2 The FAME from 1 and 2 were subjected to GC-MS [column temp. 100-250°C (rate of temp. increases 5°C/min)]. The results were as follows: FAME-1 from 1 (methyl 2-hydroxytetracosanoate), t R ϭ40.62 ( ϩ . The FAME-2 from 2 gave the same fragments like the previous one.
DMDS Derivatives of 1 and 2 Compounds 1 and 2 (1.0 mg each) were dissolved separately in carbon disulfide (0.2 ml) and iodine (1 mg) was added to the solution of each. The resulting mixtures were stored at 60°C for 40 h in two separate small-volume sealed vials. The reaction was subsequently quenched with aqueous Na 2 S 2 O 3 (5%), and mixtures were extracted with n-hexane (0.3 ml). The extracts were concentrated to give the 1 and 2 DMDS derivatives. 
